Taurolidine is a Broad-spectrum Antimicrobial for Central Venous Catheter-Related Infections Research
On November 15, 2023, the U.S. Food and Drug Administration has approved Defencath (taurolidine and heparin) catheter lock solution (CLS). CLS can reduce the incidence of catheter-related bloodstream infections in…